002: One health
Jun 05, 2020•30 min•Season 1Ep. 2
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Josh and Jason are joined this week by Andrej Spec to further discuss the data coming out on remdesivir, specifically the recently released trial examining 5 days of therapy versus 10 days. They also hit on how we are all connected through health and the need for justice.
Links for this episode:
- Comprehensive Review of Infectious Diseases (1st Edition)
- Remdesivir for 5 or 10 Days in Patients with Severe Covid–19 | NEJM
- Remdesivir in adults with severe COVID–19: a randomised, double-blind, placebo-controlled, multicentre trial | The Lancet
Have a question or comment? Drop us a line on our feedback form or send Josh or Jason a tweet.
Listen on Apple Podcasts
For the best experience, listen in Metacast app for iOS or Android